Sort
172,184 grants matching “inflammation”
Mass spectrometry and multiplexed immunofluorescence imaging of metabolic and proteomic contributors to selective neuronal vulnerability in Alzheimer's disease
$880,858Merina Thekenangarpadiyil Varghese · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AG
Safety of Allogeneic Cardiosphere-Derived Cells for Dilated Cardiomyopathy
$880,760Rachel Ruckdeschel Smith · Capricor, Inc. · R44 · FY2015 · HL
Cell lysis-induced leukotriene synthesis activates type-2 immunity in the lung
$880,735Jakob H. Von Moltke · University Of Washington · R01 · FY2025 · HL
Infection resistant surface for ventricular assist device (VAD) transcutaneous dr
$880,733Patrick Thomas Cahalan · Ension, Inc. · R44 · FY2014 · HL
Clinical, genetic and cardiometabolic risk correlates of the gut microbiome
$880,725Stanley Y Shaw · Broad Institute, Inc. · R01 · FY2019 · HL
Trafficking-Dependent Signaling of Pain by Protease-Activated Receptors
$880,716Nigel W Bunnett · New York University · R01 · FY2020 · DK
Husbandry & Management Core
$880,595Gregory Brion Timmel · University Of California At Davis · U42 · FY2025 · OD
Anti-Inflamatory Coatings for Biomaterials
$880,533La Jolla Bioengineering Institute · R01 · FY2005 · EB
Physical Resiliencies: Indicators and Mechanisms in the Elderly Collaborative
$880,501Cathleen S Colon-Emeric · Duke University · UH2 · FY2018 · AG
The Role Of Innate Immunity Genes In Viral Infection and Disease Progression
$880,488Steven R Kleeberger · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Molecular Regulation of Atherosclerosis
$880,438Hong Chen · Boston Children'S Hospital · R01 · FY2019 · HL
Pharmacologic Lysosomal Flux Activators to Ameliorate Alzheimer's Disease and Related Dementias
$880,427Jeffery W Kelly · Scripps Research Institute, The · R01 · FY2025 · AG
Obesity, Inflammation and Thrombosis: LOOK AHEAD
$880,360Christie M Ballantyne · Baylor College Of Medicine · R01 · FY2009 · HL
Stress, Environment, and Genetics in Urban Asthma
$880,300Rosalind J Wright · Brigham And Women'S Hospital · R01 · FY2009 · HL
Essential Logistic Needs to Implement the C.L.E.A.R. Phase-I HIV Vaccine Trial
$880,288Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
TL1A and its receptor DR3 in normal and autoimmune T cell responses
$880,278Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2009 · AR
programmed cell death in regulation of autoimmunity
$880,278Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2009 · AR
Functions of IL-17 Family Cytokines in Health and Disease
$880,148Ulrich Siebenlist · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Project 1 - Ethnic Differences in Smoking-Related Biomarkers and Risk of Lung Cancer
$880,118Sungshim Lani Park · University Of Minnesota · P01 · FY2019 · CA
Alzheimer's Disease Hallmark Pathology and Associated Inflammation in the Retina
$880,092Maya Koronyo-Hamaoui · Cedars-Sinai Medical Center · R01 · FY2023 · AG
Stress, Environment, and Genetics in Urban Asthma
$880,086Rosalind J Wright · Brigham And Women'S Hospital · R01 · FY2008 · HL
Immune Control of Group B Streptococcal Placental
$880,047Lakshmi Rajagopal · Seattle Children'S Hospital · R01 · FY2023 · AI
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)
$880,013David W Crabb · Indiana University Indianapolis · U01 · FY2013 · AA
CURE: DIGESTIVE DISEASES RESEARCH CENTER
$880,000University Of California Los Angeles · P30 · FY2000 · DK
Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease
$879,803Sulggi Angela Lee · University Of California, San Francisco · R33 · FY2024 · DA